Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia
- 1 November 1991
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 27 (6) , 456-463
- https://doi.org/10.1007/bf00685160
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in VivoScience, 1990
- Flavone 8-acetic acid: our current understanding of its mechanism of action in solid tumoursCancer Chemotherapy and Pharmacology, 1989
- Preclinical antitumor activity of batracylin (NSC 320846)Investigational New Drugs, 1988
- Elevated DNA polymerase beta activity in a cis-diamminedichloroplatinum(II) resistant P388 murine leukemia cell lineCancer Letters, 1988
- Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivoInvestigational New Drugs, 1987
- Arabinosyl-5-azacytosine: A novel nucleoside entering clinical trialsInvestigational New Drugs, 1987
- Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells.Proceedings of the National Academy of Sciences, 1987
- Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.Proceedings of the National Academy of Sciences, 1984
- ROLE OF TOPOISOMERASE-II IN MEDIATING EPIPODOPHYLLOTOXIN-INDUCED DNA CLEAVAGE1984
- Echinomycin: a bifunctional intercalating antibioticNature, 1974